Last updated: February 28, 2026
What Is NDC 51672-5330?
NDC 51672-5330 corresponds to a branded or generic drug, identified by the FDA's National Drug Code system. The specific product details for this NDC indicate it is a medication used in a specific therapeutic category.
Due to restrictions in available data, exact drug name, formulation, and indication are not provided. Typically, such details are available through FDA or commercial databases.
Market Size and Demand Drivers
- Therapeutic class: The drug belongs to a category with steady or increasing demand, driven by prevalence of the condition it treats.
- Market penetration: Current market size approximates $X billion (estimated based on similar drugs). The prevalence of the condition influences total addressable market.
- Competitive landscape: Multiple alternatives may exist including biosimilars or generics, influencing pricing and sales volume.
- Reimbursement environment: Medicare/Medicaid and private insurers' coverage policies impact sales potential.
Manufacturing and Distribution Factors
- Supply chain robustness: Manufacturing capacity affects potential sales volume.
- Distribution channels: Hospital-based networks, retail pharmacies, and specialty distributors are primary channels.
- Regulatory status: Approved indications, exclusivity periods, and patent protections affect market entry and duration.
Price Trends and Projections
| Year |
Average Wholesale Price (AWP) |
Estimated Market Share |
Projected Revenue (USD) |
| 2023 |
$X per unit |
15% |
$Y million |
| 2024 |
$X + 3% |
20% |
$Z million |
| 2025 |
$X + 5% |
25% |
$A million |
These projections assume current demand trends, no major competitive hurdles, and stable reimbursement policies.
Pricing Factors:
- Drug class price elasticity: For therapeutic classes with high competition, prices tend to decline.
- Biosimilar or generic entry: Lower prices often follow patent expiration or biosimilar approval.
- Inflation adjustments: Average markup increases annually around 2-3%.
Competitive Landscape and Patent Exclusivity
- Patent expiration: Scheduled for 20XX, which may lead to increased generic competition.
- Biosimilar approval: Pending biosimilar entrants could reduce price margins.
- Market exclusivity periods: Extend patent protections until 20XX, delaying generic entry.
Regulatory and Reimbursement Influences
Changes in FDA policies, including expedited approvals, impact launch timelines and market size. Reimbursement policies directly influence patient access, affecting sales revenue.
Risks to Price and Market Share
- Patent challenges or legal disputes.
- Emergence of cheaper generics or biosimilars.
- Reimbursement restrictions or formulary exclusions.
- Introduction of superior therapeutics.
Summary
Price projections for NDC 51672-5330 suggest moderate growth driven by demand stability in its therapeutic class, potential patent non-renewal, and competitive pressures. Prices are expected to stabilize or decline after patent expiry, paralleling historical patterns in similar markets.
Key Takeaways
- The market size for this medication is primarily driven by disease prevalence and treatment adoption.
- Prices are forecasted to grow slightly until patent expiration, after which generic competition will likely reduce prices substantially.
- Market entry barriers include regulatory approvals, patent exclusivity, and reimbursement policies.
- Competitive threats from biosimilars and generics pose significant risks to pricing and market share.
- Ongoing healthcare policy adjustments can alter demand and reimbursement, affecting revenue projections.
FAQs
-
What is the primary therapeutic class of NDC 51672-5330?
The specific class isn't disclosed, but typically, such NDCS belong to categories like oncology, cardiology, or autoimmune treatments.
-
How does patent expiration impact the market?
Patent expiry generally leads to increased generic competition, reducing prices and market share for branded products.
-
What factors influence the drug's market size?
Disease prevalence, treatment guidelines, competition, regulatory environment, and reimbursement policies.
-
Are biosimilars relevant for this NDC?
If it is a biologic molecule, biosimilar entry is a key factor that could lower prices upon approval.
-
What is the risk of pricing decline post-patent?
Significant, as generic and biosimilar entrants typically offer lower prices, decreasing overall revenue potential.
References
[1] U.S. FDA. (2023). National Drug Code Directory. Retrieved from https://www.accessdata.fda.gov/scripts/cder/ndc/default.cfm
[2] IQVIA. (2022). National Prescription Audit.
[3] Statista. (2023). Market size and projections for therapeutic categories.
[4] RAND Corporation. (2022). Effects of biosimilar competition on drug prices.
[5] Centers for Medicare & Medicaid Services. (2022). Reimbursement policies and drug coverage guidelines.|
Note: Specific data points for pricing, market size, and forecasts are generalized estimates based on typical patterns for similar drugs and are not specific to NDC 51672-5330.
